US Patent Issued to Novimmune on March 24 for "Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereof" (Swiss Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,922, issued on March 24, was assigned to Novimmune SA (Geneva).

"Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereof" was invented by Xavier Chauchet (Geneva), Krzysztof Masternak (Mollens, Switzerland), Limin Shang (Bellevue, Switzerland), Elise Penarrieta (Crans-Montana, Switzerland) and Walter Ferlin (Collonges-Sous-Saleve, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides bispecific antibodies that specifically bind to CD47 and Programmed Death-Ligand 1 (PD-L1). The disclosure further relates to methods of making the bispecific antibodies and nucleic acids encoding the antibodies. The disc...